Jul 13, 2026 07:00AM
Jul 13, 2026 07:00AM
Jun 23, 2026 07:01AM
Jun 23, 2026 07:00AM
May 13, 2026 04:30PM
May 7, 2026 07:00AM
May 7, 2026 07:00AM Armata Pharmaceuticals Secures FDA Fast Track Designation for AP-SA02
Apr 27, 2026 07:00AM
Apr 27, 2026 07:00AM
Mar 25, 2026 04:05PM
Mar 19, 2026 07:02AM
Mar 19, 2026 07:00AM
Feb 23, 2026 07:01AM
Feb 23, 2026 07:00AM Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product (QIDP) Designation for AP-SA02
Jan 13, 2026 07:00AM
Jan 13, 2026 07:00AM
Nov 18, 2025 07:00AM
Nov 12, 2025 04:05PM
Nov 10, 2025 07:04AM
Nov 10, 2025 07:00AM
Oct 22, 2025 11:10AM Armata reports positive Phase 2a results for bacteriophage treatment
Oct 22, 2025 11:10AM
Aug 12, 2025 04:05PM
May 20, 2025 06:39AM
May 14, 2025 04:05PM
May 1, 2025 07:03AM
May 1, 2025 07:00AM
Mar 20, 2025 05:56PM Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2024 Results and Provides Corporate Update
Mar 12, 2025 05:09PM
Mar 12, 2025 05:08PM
Nov 13, 2024 04:05PM
Nov 12, 2024 07:00AM
Jul 12, 2024 08:17AM
Jul 11, 2024 07:00AM
Aug 2, 2023 04:05PM Innoviva Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress
Aug 1, 2022 08:00AM
Aug 1, 2022 08:00AM
Feb 22, 2022 08:02AM
Feb 22, 2022 08:00AM
Nov 18, 2021 08:10AM
Nov 18, 2021 08:00AM
Mar 18, 2021 04:05PM Armata Pharmaceuticals Announces Fourth Quarter and Full Year 2020 Results and Provides General Corporate Update
Jan 27, 2021 07:01AM
Nov 12, 2020 04:05PM
Oct 29, 2020 07:55AM
Oct 29, 2020 07:30AM
Oct 15, 2020 07:32AM
Oct 15, 2020 07:30AM
Oct 31, 2019 07:05AM Armata Pharmaceuticals Issues Letter to Shareholders
Oct 10, 2019 04:05PM

325,445 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All